IFF · 8-K · 20260804PR000028

Revenue Performance and Mix

INTERNATIONAL FLAVORS & FRAGRANCES INC · 2026-08-04 · Importance 42 · Surprise 14 · Contradicted

Second-quarter 2026 reported net sales were $1.954 billion, up 2% year over year, while comparable currency-neutral sales increased 6%. Taste generated $688 million of sales, Health & Biosciences generated $601 million, and Scent generated $665 million. Currency-neutral sales increased 4% in Taste, 5% in Health & Biosciences, and 8% in Scent, with Scent led by double-digit growth in Fragrance Ingredients and high-single-digit growth in Consumer Fragrance. Fine Fragrance grew low-single digits but was affected by the Middle East conflict, while inclusive of discontinued operations sales were $2.78 billion, including $827 million from discontinued operations.

Key facts

• Inclusive of discontinued operations net sales of $827 million, net sales for the second quarter were $2.78 billion. source
• Reported net sales for the second quarter were $1.95 billion, an increase of 2% versus the prior-year period. source
• On a comparable basis, currency neutral sales in the second quarter increased 6% versus the prior-year period. source
• Second quarter reported (GAAP) sales on a continuing operations basis were $2.0 B. source
• First six months 2026 reported (GAAP) sales on a continuing operations basis were $3.9 B. source
• Reported net sales for the three months ended June 30, 2026 were $1,954 million and for the six months ended June 30, 2026 were $3,860 million according to the Consolidated Statements of Income. source
• Second quarter comparable currency neutral sales growth by segment: Taste 4%, Health & Biosciences 5%, Scent 8%, Consolidated 6%. source
• Q2 2026 Taste net sales: $679 million. source

Impact estimates